The provided text is a supplementary appendix containing a list of participating centers and a reporting checklist, and does not contain the study results.
Observational
Yes
Does TAVI improve long-term survival compared to SAVR in obese patients?
In obese patients requiring aortic valve replacement, SAVR is associated with significantly higher long-term survival rates up to 5 years compared to TAVI.
INTRODUCTION: Data on the early and late outcome following transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) in obese patients are limited. We investigated whether TAVI may be superior to SAVR in obese patients. MATERIAL AND METHODS: ) who underwent either SAVR or TAVI were identified from the nationwide OBSERVANT registry, and their in-hospital and long-term outcomes were analysed. Propensity score matching was employed to identify two cohorts with similar baseline characteristics. RESULTS: = 0.0046), with survival estimates at 1, 3 and 5 years of 88.0%, 80.3%, 71.8% for patients undergoing SAVR, and 85.2%, 69.0%, 52.8% for those subjected to TAVI procedures. CONCLUSIONS: In obese patients, both SAVR and TAVI are valid treatment options, although in the long term SAVR exhibited higher survival rates.
Mariscalco et al. (Thu,) conducted a observational in Aortic valve replacement in obese patients. Transcatheter aortic valve replacement vs. Surgical aortic valve replacement was evaluated. The provided text is a supplementary appendix containing a list of participating centers and a reporting checklist, and does not contain the study results.